glp-1 news today november 5 2025 ISPOR 2025: Exploring reasons for discontinuation Emergency Presentations of GLP-1 Agonist

Total fat mass decreased by 19.3 percent, and regional visceral fat dropped by 27.4 percent

This is why retatrutide has generated so much excitement

There are multiple GLP-1 RAs on the market, each indicated for different uses

If the breastfeeding parent requires semaglutide, they should talk to their healthcare provider about switching to another form, ideally an injectable

This involves moving beyond a one-size-fits-all approach to identify which patients will derive the most benefit

While your body's natural GLP-1 and pharmaceutical GLP-1 receptor agonists share the same basic mechanism of action, there are important differences in their structure, duration of effect, and clinical applications